Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sandy Griffith"'
Autor:
Miranda Murray, Federico Pulido, Anthony Mills, Moti Ramgopal, Roger LeBlanc, Hans Jaeger, Viviam Canon, David Dorey, Sandy Griffith, Joseph Mrus, William Spreen, David Margolis
Publikováno v:
HIV Research & Clinical Practice, Vol 20, Iss 4-5, Pp 111-122 (2019)
Background: Long-acting (LA) injectable antiretroviral therapy (ART) is a novel modality currently under development as an alternative to daily oral ART. Objective: The LATTE-2 study (ClinicalTrials.gov identifier NCT02120352) showed that cabotegravi
Externí odkaz:
https://doaj.org/article/f6a3b93b9b2d4775a89b193f0be7bb9a
Autor:
Maggie, Czarnogorski, Paul, Benn, Cindy, McCoig, Toyin, Nwafor, Sandy, Griffith, Ken, Sutton, Conn, Harrington, Parminder, Saggu, Itziar, Yague, Will, Williams, Carlos M, Español, Jessica, Goodchild, Jane, Fricker, Parul, Patel, Ronald, D'Amico
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 91:157-161
Cabotegravir + rilpivirine long-acting (LA) is a novel antiretroviral therapy (ART) administered intramuscularly monthly or every 2 months by a health care provider. The COVID-19 pandemic presents a potential challenge to patients' ability to attend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8eeef90b4563429c376ebc54511390b
https://doi.org/10.1097/qai.0000000000003031
https://doi.org/10.1097/qai.0000000000003031
Autor:
Jerry L. Jeffrey, Marty St. Clair, Ping Wang, Chunfu Wang, Zhufang Li, Jagadish Beloor, Christine Talarico, Robert Fridell, Mark Krystal, C. Thomas White, Sandy Griffith, Ronald D’Amico, Kimberly Smith, Veerle Van Eygen, Johan Vingerhoets, Kati Vandermeulen, William Spreen, Jan van Lunzen
Publikováno v:
Antimicrobial Agents and Chemotherapy. 66
The FLAIR study demonstrated noninferiority of monthly long-acting cabotegravir + rilpivirine versus daily oral dolutegravir/abacavir/lamivudine for maintaining virologic suppression. Three participants who received long-acting therapy had confirmed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::853db3a1c7425ded74759ab3715e3787
https://doi.org/10.1128/aac.01702-21
https://doi.org/10.1128/aac.01702-21
Autor:
Miranda Murray, David Dorey, Simon Vanveggel, Enrique Bernal, Anthony Mills, Jenny Huang, Sharon Walmsley, David A. Margolis, Hans Jäger, Mark S. Shaefer, Vasiliki Chounta, Marie-Aude Khuong-Josses, Krischan J Hudson, Sandy Griffith, William Spreen, Harold P. Katner, Antonio Antela, Johan Lombaard
Publikováno v:
AIDS and Behavior
The phase 3 ATLAS and FLAIR studies demonstrated that maintenance with Long-Acting (LA) intramuscular cabotegravir and rilpivirine is non-inferior in efficacy to current antiretroviral (CAR) oral therapy. Both studies utilized Patient-Reported Outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b688b7e4c1686a477ccac43d01accfdc
https://doi.org/10.1007/s10461-020-02929-8
https://doi.org/10.1007/s10461-020-02929-8
Autor:
Wendy A. Davis, Susan Swindells, Rafael Rubio García, Miranda Murray, Mercedes Garcia Gasalla, Krischan J Hudson, Princy Kumar, Sandy Griffith, Tahilin S. Karver, U. Fritz Bredeek, Deanna Kerrigan, Miguel García del Toro, Antonio Antela, Andrea Mantsios, David Margolis
Publikováno v:
AIDS and Behavior. 24:3473-3481
Long-acting injectable antiretroviral therapy (LA ART) may be an alternative for people living with HIV (PLHIV) with adherence challenges or who prefer not to take pills. Using in-depth interviews, this study sought to understand the experiences of P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d26d9d0afdff4b07c079221f9dddaf
https://doi.org/10.1007/s10461-020-02918-x
https://doi.org/10.1007/s10461-020-02918-x
Autor:
Anthony Mills, Federico Pulido, Joseph M. Mrus, William Spreen, David Dorey, Viviam Canon, Moti Ramgopal, David A. Margolis, Sandy Griffith, Miranda Murray, Hans Jaeger, Roger LeBlanc
Publikováno v:
HIV Research & Clinical Practice. 20:111-122
Background: Long-acting (LA) injectable antiretroviral therapy (ART) is a novel modality currently under development as an alternative to daily oral ART.Objective: The LATTE-2 study (ClinicalTrials...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a05a2a2dffa26cb8e3e9076d6cc891e
https://doi.org/10.1080/25787489.2019.1661696
https://doi.org/10.1080/25787489.2019.1661696
Autor:
Shanker Thiagarajah, Sandy Griffith, Hans-Jürgen Stellbrink, Ronald D'Amico, Chloe Orkin, Elena Belonosova, Rebecca DeMoor, Darrell H. S. Tan, Kati Vandermeulen, Parul Patel, Herta Crauwels, William Spreen, Kimberly Y. Smith, Marty St. Clair, Susan L. Ford, Enrique Bernal Morell, Harold P. Katner, Eileen Birmingham, Rodica Van Solingen-Ristea, Amy Cutrell
Publikováno v:
The lancet. HIV. 8(11)
Previous work established non-inferiority of switching participants who were virologically suppressed from daily oral standard of care to monthly long-acting intramuscular injections of cabotegravir plus rilpivirine over 96 weeks following a cabotegr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fa6060febb74d51fcb13a78322e7bfd
https://pubmed.ncbi.nlm.nih.gov/34656209
https://pubmed.ncbi.nlm.nih.gov/34656209
Autor:
David Dorey, William Spreen, Veerle Van Eygen, Darrell H. S. Tan, Parul Patel, Kati Vandermeulen, Denis Gusev, Ronald D'Amico, Patrick Philibert, Chloe Orkin, Kimberly Y. Smith, Simon Vanveggel, Susan L. Ford, Juan González García, Vasiliki Chounta, Enrique Bernal Morell, Shinichi Oka, Herta Crauwels, Marty St. Clair, Olaf Degen, Ayesha Bassa, David A. Margolis, Cynthia Brinson, Sandy Griffith, Shanker Thiagarajah, Rodica Van Solingen-Ristea, Amy Cutrell
Publikováno v:
The lancet. HIV. 8(4)
There is a need for more convenient, less frequent treatment to help address challenges associated with daily oral HIV treatment in people living with HIV, including stigma, pill burden, drug-food interactions, and adherence. The phase 3 ATLAS and FL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a5d8a189cc9adbd36436b7adc0c67f
https://pubmed.ncbi.nlm.nih.gov/34391566
https://pubmed.ncbi.nlm.nih.gov/34391566
Autor:
Pierre-Marie Girard, Chris Bettacchi, Amy Cutrell, Shinichi Oka, Vasiliki Chounta, Miguel de Górgolas Hernández-Mora, Cynthia Brinson, Marty St. Clair, Herta Crauwels, David Dorey, Vadim Pokrovsky, Wim Louis Julien Parys, William Spreen, Edgar T. Overton, Patrick Philibert, Kimberly Y. Smith, Johan Lombaard, Chloe Orkin, Sharon Walmsley, Peter Williams, David A. Margolis, Sandy Griffith, Susan L. Ford, Ronald D'Amico, Keikawus Arastéh, Simon Vanveggel, Parul Patel
Publikováno v:
The New England journal of medicine. 382(12)
Long-acting injectable regimens may simplify therapy for patients with human immunodeficiency virus type 1 (HIV-1) infection.We conducted a phase 3, randomized, open-label trial in which adults with HIV-1 infection who had not previously received ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37add18b32108939936be88a3b3b0400
https://pubmed.ncbi.nlm.nih.gov/32130808
https://pubmed.ncbi.nlm.nih.gov/32130808
Autor:
Jaime Andrade-Villanueva, Amy Cutrell, Joseph M. Mrus, Veerle Van Eygen, William Spreen, Axel Baumgarten, Edgar T. Overton, Mar Masiá, Angela Wills, Susan L. Ford, Sterling Wu, Ken Chow, Giuliano Rizzardini, Vadim Pokrovsky, Keikawus Arastéh, Gulam H Latiff, Chloe Orkin, Sandy Griffith, Ronald D'Amico, Rodica Van Solingen-Ristea, Conn M. Harrington, Herta Crauwels, Shinichi Oka, Christine L. Talarico, Jeremy Roberts, Gary Richmond, Krischan J Hudson, Miguel de Górgolas Hernández-Mora, Susan Swindells, Kimberly Y. Smith, David A. Margolis, Marty St. Clair, Parul Patel, Simon Vanveggel, Pierre Marie Girard, Nicola Walters
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Journal of Acquired Immune Deficiency Syndromes (1999)
instname
Journal of Acquired Immune Deficiency Syndromes (1999)
HIV remains a major global health concern, with the Joint United Nations Programme on HIV/AIDS and the World Health Organization (WHO) estimating the number of people living with HIV (PLWH) to be ∼37.9 million in 2018.1,2 Improvements in HIV treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d982fc10553dbbfcbcd25d10d307cb
http://hdl.handle.net/10486/697840
http://hdl.handle.net/10486/697840
